{"id":5647,"date":"2022-08-30T11:54:24","date_gmt":"2022-08-30T11:54:24","guid":{"rendered":"https:\/\/blog.caixaresearch.org\/?p=5647"},"modified":"2022-08-30T11:54:24","modified_gmt":"2022-08-30T11:54:24","slug":"identificada-una-nova-linia-de-probiotics-per-tractar-lobesitat-i-la-diabetis","status":"publish","type":"post","link":"https:\/\/blog.caixaresearch.org\/ca\/identificada-una-nova-linia-de-probiotics-per-tractar-lobesitat-i-la-diabetis\/","title":{"rendered":"Identificada una nova l\u00ednia de probi\u00f2tics per tractar l&#8217;obesitat i la diabetis"},"content":{"rendered":"<p><iframe loading=\"lazy\" title=\"YouTube video player\" src=\"https:\/\/www.youtube.com\/embed\/tY6RvvFQZ6s\" width=\"400\" height=\"225\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<p><span style=\"font-weight: 300;\">Un estudi publicat a la prestigiosa revista Microbiome i liderat pel grup DIAMET, amb <\/span><span style=\"font-weight: 300;\">investigadors i investigadores de l&#8217;Institut d&#8217;Investigaci\u00f3 Sanit\u00e0ria Pere Virgi (IISPV)-<\/span><span style=\"font-weight: 300;\">CERCA, la Universitat Rovira i Virgili (URV) i el Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM) ha perm\u00e8s trobar <\/span><b>una nova via terap\u00e8utica per al tractament de malalties inflamat\u00f2ries i metab\u00f2liques com l&#8217;obesitat o la diabetis tipus 2<\/b><span style=\"font-weight: 300;\">.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 300;\">En concret, la investigaci\u00f3, que ha rebut el suport de la Fundaci\u00f3 \u201cla Caixa\u201d, suggereix que <\/span><b>la salut metab\u00f2lica de les persones amb aquestes malalties podria experimentar una millora en aconseguir disminuir-los els nivells de succinat a la sang mitjan\u00e7ant l&#8217;administraci\u00f3 d&#8217;uns bacteris espec\u00edfics que actuen com a probi\u00f2tics<\/b><span style=\"font-weight: 300;\">.<\/span><\/p>\n<p><span style=\"font-weight: 300;\">El succinat \u00e9s un metab\u00f2lit amb m\u00faltiples funcions que produeixen de forma natural les c\u00e8l\u00b7lules del nostre organisme i els bacteris intestinals o microbiota. En malalties <\/span><span style=\"font-weight: 300;\">metab\u00f2liques i inflamat\u00f2ries com l&#8217;obesitat i la diabetis, on hi ha una alteraci\u00f3 de la <\/span><span style=\"font-weight: 300;\">microbiota intestinal, els nivells de producci\u00f3 d&#8217;aquest metab\u00f2lit es troben elevats, fet que est\u00e0 directament relacionat amb la inflamaci\u00f3 caracter\u00edstica en aquest tipus de <\/span><span style=\"font-weight: 300;\">pacients.<\/span><\/p>\n<p><span style=\"font-weight: 300;\">Precisament, diversos estudis previs de DIAMET, el grup de recerca que ha liderat <\/span><span style=\"font-weight: 300;\">aquest estudi i que coordinen els doctors Sonia Fern\u00e1ndez-Veledo, investigadora de la xarxa CaixaResearch, i Joan Vendrell, havien demostrat que <\/span><b>detectar uns nivells elevats a la sang d&#8217;aquest metab\u00f2lit indica que la persona no gaudeix d&#8217;una bona salut metab\u00f2lica i que, per tant, t\u00e9 m\u00e9s risc de desenvolupar altres patologies en un futur. Per tot aix\u00f2, aquest indicador \u00e9s clau<\/b><span style=\"font-weight: 300;\">.<\/span><\/p>\n<p><span style=\"font-weight: 300;\">\u201cEn investigacions pr\u00e8vies del nostre grup b\u00e0sicament mostr\u00e0vem que aquests pacients tenien m\u00e9s bacteris productors de succinat i menys bacteris dels que el consumeixen, per\u00f2 no hav\u00edem aconseguit provar una relaci\u00f3 directa causal. En aquesta investigaci\u00f3 i mitjan\u00e7ant l&#8217;\u00fas de models animals obesos lliures de microbiota, <\/span><b>demostrem per primer cop que la microbiota intestinal \u00e9s l&#8217;origen dels nivells augmentats de succinat en obesitat i diabetis<\/b><span style=\"font-weight: 300;\">\u201d, explica Sonia Fern\u00e1ndez-Veledo. I afegeix: \u201caquesta nova l\u00ednia de probi\u00f2tics es basa en l&#8217;\u00fas de bacteris consumidors de succinat, que disminuirien la inflamaci\u00f3 i, en conseq\u00fc\u00e8ncia, millorarien els nivells gluc\u00e8mics i la sensibilitat a la insulina, dos aspectes que es troben alterats en el cas de les persones amb diabetis\u201d.<\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-5648\" src=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/08\/SoniaFernandez_CAT-300x157.jpg\" alt=\"\" width=\"400\" height=\"209\" srcset=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/08\/SoniaFernandez_CAT-300x157.jpg 300w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/08\/SoniaFernandez_CAT-1024x535.jpg 1024w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/08\/SoniaFernandez_CAT-768x401.jpg 768w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/08\/SoniaFernandez_CAT-1536x802.jpg 1536w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/08\/SoniaFernandez_CAT-2048x1070.jpg 2048w\" sizes=\"auto, (max-width: 400px) 100vw, 400px\" \/><br \/>\n<em>Sonia Fern\u00e1ndez Veledo<\/em><\/p>\n<p><span style=\"font-weight: 300;\">Investigar en aquests \u00e0mbits \u00e9s crucial, ja que segons dades de l&#8217;Organitzaci\u00f3 Mundial de la Salut (OMS) la incid\u00e8ncia de l&#8217;obesitat a la poblaci\u00f3 mundial s&#8217;ha triplicat els darrers 50 anys. Aquesta malaltia constitueix el factor de risc m\u00e9s important per al desenvolupament de la diabetis, trastorn que, alhora, \u00e9s considerat per l&#8217;OMS la novena causa m\u00e9s important de mort al m\u00f3n. La majoria de les persones que la pateixen (un 80%) s\u00f3n obeses.<\/span><\/p>\n<p><b><i>Probi\u00f2tics que revolucionen el mercat<\/i><\/b><\/p>\n<p><span style=\"font-weight: 300;\">\u201cDespr\u00e9s de demostrar que aquest augment del succinat ve de la microbiota ens vam <\/span><span style=\"font-weight: 300;\">fer les seg\u00fcents preguntes: si administrem un bacteri que consumeixi succinat n\u2019aconseguirem disminuir els nivells circulants?, i si disminu\u00efm els nivells circulants <\/span><span style=\"font-weight: 300;\">millorarem el perfil metab\u00f2lic?\u201d, explica Isabel Huber, investigadora de la xarxa CaixaResearch i primera autora signant de l&#8217;article cient\u00edfic.\u00a0<\/span><\/p>\n<p><b>Aquesta nova l\u00ednia de probi\u00f2tics permet, a m\u00e9s, monitorar la seva efectivitat<\/b><\/p>\n<p><b>en temps real, ja que \u201cgr\u00e0cies a aquest estudi, ara en coneixem el mecanisme d&#8217;acci\u00f3, i, per altra banda, el resultat de l&#8217;activitat d&#8217;aquests bacteris \u00e9s f\u00e0cilment mesurable a la sang\u201d<\/b><span style=\"font-weight: 300;\">, declara Isabel Huber. I afegeix: \u201cSi b\u00e9 es coneix que molts dels probi\u00f2tics que avui dia es troben al mercat s\u00f3n beneficiosos, moltes vegades es desconeix realment com actuen i, per tant, no se&#8217;n pot determinar de manera objectiva el seu efecte\u201d.<\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-5650\" src=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/08\/IsabelHuber_CAT-300x157.jpg\" alt=\"\" width=\"400\" height=\"209\" srcset=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/08\/IsabelHuber_CAT-300x157.jpg 300w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/08\/IsabelHuber_CAT-1024x535.jpg 1024w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/08\/IsabelHuber_CAT-768x401.jpg 768w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/08\/IsabelHuber_CAT-1536x802.jpg 1536w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/08\/IsabelHuber_CAT-2048x1070.jpg 2048w\" sizes=\"auto, (max-width: 400px) 100vw, 400px\" \/><br \/>\n<em>Isabel Huber<\/em><\/p>\n<p><b>L&#8217;objectiu de l\u2019equip de recerca \u00e9s que aquests probi\u00f2tics s\u2019acabin comercialitzant i que serveixin perqu\u00e8 les persones amb trastorns metab\u00f2lics i inflamatoris (l&#8217;obesitat o la diabetis<\/b><span style=\"font-weight: 300;\">, per\u00f2 tamb\u00e9 altres malalties, com el Crohn o la del fetge gras no alcoh\u00f2lic) puguin trobar una nova via, m\u00e9s efectiva, per al tractament. \u00c9s a trav\u00e9s de l\u2019<\/span><b>spin-off Succipro, que neix fruit d&#8217;anys de recerca de DIAMET en aquesta l\u00ednia, que aquests probi\u00f2tics estan sent desenvolupats<\/b><span style=\"font-weight: 300;\">. A m\u00e9s, l&#8217;empresa treballa en altres ter\u00e0pies, tamb\u00e9 basades en la disminuci\u00f3 del succinat, per al tractament d&#8217;aquest tipus de malalties.<\/span><\/p>\n<p><span style=\"font-weight: 300;\">Aquesta investigaci\u00f3 ha estat possible gr\u00e0cies a la col\u00b7laboraci\u00f3 de l\u2019Institut <\/span><span style=\"font-weight: 300;\">d\u2019Investigaci\u00f3 Biom\u00e8dica de Girona (IDIBGI), de l\u2019Institut Nacional d\u2019Investigaci\u00f3 en <\/span><span style=\"font-weight: 300;\">Salut i Medicina de Fran\u00e7a (INSERM) i de les empreses Biomathematica i Probiotical <\/span><span style=\"font-weight: 300;\">(It\u00e0lia). <\/span><b>D\u2019altra banda, ha pogut portar-se a terme gr\u00e0cies al suport rebut per part de la Fundaci\u00f3 &#8220;la Caixa&#8221; (mitjan\u00e7ant les seves l\u00ednies d\u2019ajuts a projectes d\u2019innovaci\u00f3 de <\/b><b>CaixaResearch Validate i a projectes biom\u00e8dics CaixaResearch, d\u2019investigaci\u00f3 en salut)<\/b><span style=\"font-weight: 300;\">, del Ministerio de Ciencia e Innovaci\u00f3n, del Instituto de Salud Carlos III, de l\u2019Ag\u00e8ncia de Gesti\u00f3 d&#8217;Ajuts Universitaris i de Recerca de la Generalitat de Catalunya (AGAUR) i de la Fundaci\u00f3n para la Innovaci\u00f3n y la Prospectiva en Espa\u00f1a (FIPSE).<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p><iframe loading=\"lazy\" title=\"YouTube video player\" src=\"https:\/\/www.youtube.com\/embed\/tY6RvvFQZ6s\" width=\"400\" height=\"225\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<p>Un estudi publicat a la prestigiosa revista Microbiome i liderat pel grup DIAMET, amb investigadors i investigadores de l&#8217;Institut d&#8217;Investigaci\u00f3 Sanit\u00e0ria Pere Virgi (IISPV)-CERCA, la Universitat Rovira i Virgili (URV) i el Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM) ha perm\u00e8s trobar una nova via terap\u00e8utica per al tractament de malalties inflamat\u00f2ries i metab\u00f2liques com l&#8217;obesitat o la diabetis tipus 2.\u00a0<\/p>\n<p>En concret, la investigaci\u00f3, que ha rebut el suport de la Fundaci\u00f3 \u201cla Caixa\u201d, suggereix que la salut metab\u00f2lica de les persones amb aquestes malalties podria experimentar una millora en aconseguir disminuir-los els nivells de succinat a la sang mitjan\u00e7ant l&#8217;administraci\u00f3 d&#8217;uns bacteris espec\u00edfics que actuen com a probi\u00f2tics.<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[520],"tags":[],"class_list":["post-5647","post","type-post","status-publish","format-standard","hentry","category-divulgacio-cientifica"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Identificada una nova l\u00ednia de probi\u00f2tics per tractar l&#039;obesitat i la diabetis - Blog CaixaCi\u00e8ncia<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blog.caixaresearch.org\/ca\/identificada-una-nova-linia-de-probiotics-per-tractar-lobesitat-i-la-diabetis\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Identificada una nova l\u00ednia de probi\u00f2tics per tractar l&#039;obesitat i la diabetis - Blog CaixaCi\u00e8ncia\" \/>\n<meta property=\"og:description\" content=\"Un estudi publicat a la prestigiosa revista Microbiome i liderat pel grup DIAMET, amb investigadors i investigadores de l&#8217;Institut d&#8217;Investigaci\u00f3 Sanit\u00e0ria Pere Virgi (IISPV)-CERCA, la Universitat Rovira i Virgili (URV) i el Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM) ha perm\u00e8s trobar una nova via terap\u00e8utica per al tractament de malalties inflamat\u00f2ries i metab\u00f2liques com l&#8217;obesitat o la diabetis tipus 2.\u00a0 En concret, la investigaci\u00f3, que ha rebut el suport de la Fundaci\u00f3 \u201cla Caixa\u201d, suggereix que la salut metab\u00f2lica de les persones amb aquestes malalties podria experimentar una millora en aconseguir disminuir-los els nivells de succinat a la sang mitjan\u00e7ant l&#8217;administraci\u00f3 d&#8217;uns bacteris espec\u00edfics que actuen com a probi\u00f2tics.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blog.caixaresearch.org\/ca\/identificada-una-nova-linia-de-probiotics-per-tractar-lobesitat-i-la-diabetis\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog CaixaCi\u00e8ncia\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-30T11:54:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/08\/SoniaFernandez_CAT-300x157.jpg\" \/>\n<meta name=\"author\" content=\"Ubikmedia\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ubikmedia\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/blog.caixaresearch.org\/ca\/identificada-una-nova-linia-de-probiotics-per-tractar-lobesitat-i-la-diabetis\/\",\"url\":\"https:\/\/blog.caixaresearch.org\/ca\/identificada-una-nova-linia-de-probiotics-per-tractar-lobesitat-i-la-diabetis\/\",\"name\":\"Identificada una nova l\u00ednia de probi\u00f2tics per tractar l'obesitat i la diabetis - Blog CaixaCi\u00e8ncia\",\"isPartOf\":{\"@id\":\"https:\/\/blog.caixaresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/blog.caixaresearch.org\/ca\/identificada-una-nova-linia-de-probiotics-per-tractar-lobesitat-i-la-diabetis\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/blog.caixaresearch.org\/ca\/identificada-una-nova-linia-de-probiotics-per-tractar-lobesitat-i-la-diabetis\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/08\/SoniaFernandez_CAT-300x157.jpg\",\"datePublished\":\"2022-08-30T11:54:24+00:00\",\"author\":{\"@id\":\"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/2b9d5310c27055b4862191402c387fca\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/blog.caixaresearch.org\/ca\/identificada-una-nova-linia-de-probiotics-per-tractar-lobesitat-i-la-diabetis\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/blog.caixaresearch.org\/ca\/identificada-una-nova-linia-de-probiotics-per-tractar-lobesitat-i-la-diabetis\/#primaryimage\",\"url\":\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/08\/SoniaFernandez_CAT-300x157.jpg\",\"contentUrl\":\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/08\/SoniaFernandez_CAT-300x157.jpg\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/blog.caixaresearch.org\/#website\",\"url\":\"https:\/\/blog.caixaresearch.org\/\",\"name\":\"Blog CaixaCi\u00e8ncia\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/blog.caixaresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/2b9d5310c27055b4862191402c387fca\",\"name\":\"Ubikmedia\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ccc66bc497f8ba496f9d06e5a58a91de?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ccc66bc497f8ba496f9d06e5a58a91de?s=96&d=mm&r=g\",\"caption\":\"Ubikmedia\"},\"url\":\"https:\/\/blog.caixaresearch.org\/ca\/author\/ubikmedia\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Identificada una nova l\u00ednia de probi\u00f2tics per tractar l'obesitat i la diabetis - Blog CaixaCi\u00e8ncia","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blog.caixaresearch.org\/ca\/identificada-una-nova-linia-de-probiotics-per-tractar-lobesitat-i-la-diabetis\/","og_locale":"ca_ES","og_type":"article","og_title":"Identificada una nova l\u00ednia de probi\u00f2tics per tractar l'obesitat i la diabetis - Blog CaixaCi\u00e8ncia","og_description":"Un estudi publicat a la prestigiosa revista Microbiome i liderat pel grup DIAMET, amb investigadors i investigadores de l&#8217;Institut d&#8217;Investigaci\u00f3 Sanit\u00e0ria Pere Virgi (IISPV)-CERCA, la Universitat Rovira i Virgili (URV) i el Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM) ha perm\u00e8s trobar una nova via terap\u00e8utica per al tractament de malalties inflamat\u00f2ries i metab\u00f2liques com l&#8217;obesitat o la diabetis tipus 2.\u00a0 En concret, la investigaci\u00f3, que ha rebut el suport de la Fundaci\u00f3 \u201cla Caixa\u201d, suggereix que la salut metab\u00f2lica de les persones amb aquestes malalties podria experimentar una millora en aconseguir disminuir-los els nivells de succinat a la sang mitjan\u00e7ant l&#8217;administraci\u00f3 d&#8217;uns bacteris espec\u00edfics que actuen com a probi\u00f2tics.","og_url":"https:\/\/blog.caixaresearch.org\/ca\/identificada-una-nova-linia-de-probiotics-per-tractar-lobesitat-i-la-diabetis\/","og_site_name":"Blog CaixaCi\u00e8ncia","article_published_time":"2022-08-30T11:54:24+00:00","og_image":[{"url":"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/08\/SoniaFernandez_CAT-300x157.jpg","type":"","width":"","height":""}],"author":"Ubikmedia","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"Ubikmedia","Temps estimat de lectura":"5 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/blog.caixaresearch.org\/ca\/identificada-una-nova-linia-de-probiotics-per-tractar-lobesitat-i-la-diabetis\/","url":"https:\/\/blog.caixaresearch.org\/ca\/identificada-una-nova-linia-de-probiotics-per-tractar-lobesitat-i-la-diabetis\/","name":"Identificada una nova l\u00ednia de probi\u00f2tics per tractar l'obesitat i la diabetis - Blog CaixaCi\u00e8ncia","isPartOf":{"@id":"https:\/\/blog.caixaresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/blog.caixaresearch.org\/ca\/identificada-una-nova-linia-de-probiotics-per-tractar-lobesitat-i-la-diabetis\/#primaryimage"},"image":{"@id":"https:\/\/blog.caixaresearch.org\/ca\/identificada-una-nova-linia-de-probiotics-per-tractar-lobesitat-i-la-diabetis\/#primaryimage"},"thumbnailUrl":"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/08\/SoniaFernandez_CAT-300x157.jpg","datePublished":"2022-08-30T11:54:24+00:00","author":{"@id":"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/2b9d5310c27055b4862191402c387fca"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blog.caixaresearch.org\/ca\/identificada-una-nova-linia-de-probiotics-per-tractar-lobesitat-i-la-diabetis\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/blog.caixaresearch.org\/ca\/identificada-una-nova-linia-de-probiotics-per-tractar-lobesitat-i-la-diabetis\/#primaryimage","url":"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/08\/SoniaFernandez_CAT-300x157.jpg","contentUrl":"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/08\/SoniaFernandez_CAT-300x157.jpg"},{"@type":"WebSite","@id":"https:\/\/blog.caixaresearch.org\/#website","url":"https:\/\/blog.caixaresearch.org\/","name":"Blog CaixaCi\u00e8ncia","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blog.caixaresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Person","@id":"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/2b9d5310c27055b4862191402c387fca","name":"Ubikmedia","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ccc66bc497f8ba496f9d06e5a58a91de?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ccc66bc497f8ba496f9d06e5a58a91de?s=96&d=mm&r=g","caption":"Ubikmedia"},"url":"https:\/\/blog.caixaresearch.org\/ca\/author\/ubikmedia\/"}]}},"_links":{"self":[{"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/posts\/5647","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/comments?post=5647"}],"version-history":[{"count":1,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/posts\/5647\/revisions"}],"predecessor-version":[{"id":5652,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/posts\/5647\/revisions\/5652"}],"wp:attachment":[{"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/media?parent=5647"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/categories?post=5647"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/tags?post=5647"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}